ConductScience.org, home

Paper30103348

Centronuclear myopathies under attack: A plethora of therapeutic targets.

Tasfaout H and 2 others. J Neuromuscul Dis, 2018. Cited by 37 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Centronuclear myopathies under attack: A plethora of therapeutic targets. Papers, record 30103348. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30103348

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Centronuclear myopathies under attack: A plethora of therapeutic targets.
PubMed
Journal
J Neuromuscul Dis
PubMed
Year
2018
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
37
iCite
Relative citation ratio, by iCite
1.25
iCite
Revised in PubMed
2019-01-31
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tasfaout HHichem
2Cowling BSBelinda S
3Laporte JJocelyn

Source PubMed

Download CSV of authors

Topics3

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Myopathies, Structural, CongenitalMajor topic
Animals
Humans

References165

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117537630Myofiber size correlates with MTM1 mutation type and outcome in X-linked myotubular myopathy.Neuromuscul Disord2007https://conductscience.org/library/papers/17537630PubMed
220227276Expanding the clinical, pathological and MRI phenotype of DNM2-related centronuclear myopathy.Neuromuscul Disord2010https://conductscience.org/library/papers/20227276PubMed
324726641Differential muscle hypertrophy is associated with satellite cell numbers and Akt pathway activation following activin type IIB receptor inhibition in Mtm1 p.R69C mice.Am J Pathol2014https://conductscience.org/library/papers/24726641PubMed
418817572Centronuclear (myotubular) myopathy.Orphanet J Rare Dis2008https://conductscience.org/library/papers/18817572PubMed
520379207The emerging mechanisms of isoform-specific PI3K signalling.Nat Rev Mol Cell Biol2010https://conductscience.org/library/papers/20379207PubMed
628370029Long-term effects of systemic gene therapy in a canine model of myotubular myopathy.Muscle Nerve2017https://conductscience.org/library/papers/28370029PubMed
711846405Functional redundancy in the myotubularin family.Biochem Biophys Res Commun2002https://conductscience.org/library/papers/11846405PubMed
821737882Mice lacking microRNA 133a develop dynamin 2–dependent centronuclear myopathy.J Clin Invest2011https://conductscience.org/library/papers/21737882PubMed
929246969Allele-specific silencing therapy for Dynamin 2-related dominant centronuclear myopathy.EMBO Mol Med2018https://conductscience.org/library/papers/29246969PubMed
1022818856Dominant mutation of CCDC78 in a unique congenital myopathy with prominent internal nuclei and atypical cores.Am J Hum Genet2012https://conductscience.org/library/papers/22818856PubMed
1118434328AAV-mediated intramuscular delivery of myotubularin corrects the myotubular myopathy phenotype in targeted murine muscle and suggests a function in plasma membrane homeostasis.Hum Mol Genet2008https://conductscience.org/library/papers/18434328PubMed
1211504939Characterization of an adapter subunit to a phosphatidylinositol (3)P 3-phosphatase: identification of a myotubularin-related protein lacking catalytic activity.Proc Natl Acad Sci U S A2001https://conductscience.org/library/papers/11504939PubMed
1322717743Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial.Gene Ther2013https://conductscience.org/library/papers/22717743PubMed
149438853Role of dynamin in the formation of transport vesicles from the trans-Golgi network.Science1998https://conductscience.org/library/papers/9438853PubMed
159398675Ubiquitously expressed dynamin-II has a higher intrinsic GTPase activity and a greater propensity for self-assembly than neuronal dynamin-I.Mol Biol Cell1997https://conductscience.org/library/papers/9398675PubMed
1629408998Intravenous Administration of a MTMR2-Encoding AAV Vector Ameliorates the Phenotype of Myotubular Myopathy in Mice.J Neuropathol Exp Neurol2018https://conductscience.org/library/papers/29408998PubMed
1720723755Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival.Cell2010https://conductscience.org/library/papers/20723755PubMed
1822068590Modeling the human MTM1 p.R69C mutation in murine Mtm1 results in exon 4 skipping and a less severe myotubular myopathy phenotype.Hum Mol Genet2012https://conductscience.org/library/papers/22068590PubMed
1923975875Recessive truncating titin gene, TTN, mutations presenting as centronuclear myopathy.Neurology2013https://conductscience.org/library/papers/23975875PubMed
2019498037Correction of tau mis-splicing caused by FTDP-17 MAPT mutations by spliceosome-mediated RNA trans-splicing.Hum Mol Genet2009https://conductscience.org/library/papers/19498037PubMed

See all 165 referencesDownload CSV of references

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.

PMIDTitleJournalYearIn PapersSource
42717511X-linked myotubular myopathy, liver disease, and gene therapy.J Neuromuscul Dis2026https://conductscience.org/library/papers/42717511PubMed
42201138Beyond Membrane Remodeling: Organelle Crosstalk and Convergent Pathology in Centronuclear Myopathy.Muscles2026https://conductscience.org/library/papers/42201138PubMed
41321131Dynamic expression and differential requirement of the myocyte fusogen Myomixer during distinct myogenic episodes in the zebrafish.Biol Open2025https://conductscience.org/library/papers/41321131PubMed
38805272MTM1-mediated production of phosphatidylinositol 5-phosphate fuels the formation of podosome-like protrusions regulating myoblast fusion.Proc Natl Acad Sci U S A2024https://conductscience.org/library/papers/38805272PubMed
38364889Phosphoinositide switches in cell physiology - From molecular mechanisms to disease.J Biol Chem2024https://conductscience.org/library/papers/38364889PubMed
37490339Loss of Mtm1 causes cholestatic liver disease in a model of X-linked myotubular myopathy.J Clin Invest2023https://conductscience.org/library/papers/37490339PubMed
36943412Inactivating the lipid kinase activity of PI3KC2β is sufficient to rescue myotubular myopathy in mice.JCI Insight2023https://conductscience.org/library/papers/36943412PubMed
36369230Differential impact of ubiquitous and muscle dynamin 2 isoforms in muscle physiology and centronuclear myopathy.Nat Commun2022https://conductscience.org/library/papers/36369230PubMed
36161941Antagonistic control of active surface integrins by myotubularin and phosphatidylinositol 3-kinase C2β in a myotubular myopathy model.Proc Natl Acad Sci U S A2022https://conductscience.org/library/papers/36161941PubMed
35293586Characterization of a novel zebrafish model of SPEG-related centronuclear myopathy.Dis Model Mech2022https://conductscience.org/library/papers/35293586PubMed
34768808Common Pathogenic Mechanisms in Centronuclear and Myotubular Myopathies and Latest Treatment Advances.Int J Mol Sci2021https://conductscience.org/library/papers/34768808PubMed
34685492Muscle Regeneration and RNA: New Perspectives for Ancient Molecules.Cells2021https://conductscience.org/library/papers/34685492PubMed
34371181Mice with muscle-specific deletion of Bin1 recapitulate centronuclear myopathy and acute downregulation of dynamin 2 improves their phenotypes.Mol Ther2022https://conductscience.org/library/papers/34371181PubMed
34297919Genetic diseases in the omics era.Mol Ther2021https://conductscience.org/library/papers/34297919PubMed
34257452Molecular and cellular basis of genetically inherited skeletal muscle disorders.Nat Rev Mol Cell Biol2021https://conductscience.org/library/papers/34257452PubMed
34072258Striated Preferentially Expressed Protein Kinase (SPEG) in Muscle Development, Function, and Disease.Int J Mol Sci2021https://conductscience.org/library/papers/34072258PubMed
33940157Multi-omics comparisons of different forms of centronuclear myopathies and the effects of several therapeutic strategies.Mol Ther2021https://conductscience.org/library/papers/33940157PubMed
33926407Clinical and genetic analysis of a case with centronuclear myopathy caused by SPEG gene mutation: a case report and literature review.BMC Pediatr2021https://conductscience.org/library/papers/33926407PubMed
33407688Hierarchical Bayesian modelling of disease progression to inform clinical trial design in centronuclear myopathy.Orphanet J Rare Dis2021https://conductscience.org/library/papers/33407688PubMed
33355670SPEG binds with desmin and its deficiency causes defects in triad and focal adhesion proteins.Hum Mol Genet2021https://conductscience.org/library/papers/33355670PubMed

See all 27 cited byDownload CSV of cited by

Genes19

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACHE43PubTator's text mininghttps://conductscience.org/library/genes/43NCBI Gene
ACVR2B93PubTator's text mininghttps://conductscience.org/library/genes/93NCBI Gene
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
BIN1274PubTator's text mininghttps://conductscience.org/library/genes/274NCBI Gene
CACNA1S779PubTator's text mininghttps://conductscience.org/library/genes/779NCBI Gene
DES1674PubTator's text mininghttps://conductscience.org/library/genes/1674NCBI Gene
DNM21785PubTator's text mininghttps://conductscience.org/library/genes/1785NCBI Gene
MSTN2660PubTator's text mininghttps://conductscience.org/library/genes/2660NCBI Gene
MT1DP326343PubTator's text mininghttps://conductscience.org/library/genes/326343NCBI Gene
MTM14534PubTator's text mininghttps://conductscience.org/library/genes/4534NCBI Gene
MTMR28898PubTator's text mininghttps://conductscience.org/library/genes/8898NCBI Gene
MTOR2475PubTator's text mininghttps://conductscience.org/library/genes/2475NCBI Gene
PAH5053PubTator's text mininghttps://conductscience.org/library/genes/5053NCBI Gene
PIK3C2B5287PubTator's text mininghttps://conductscience.org/library/genes/5287NCBI Gene
PIK3C35289PubTator's text mininghttps://conductscience.org/library/genes/5289NCBI Gene
RYR16261PubTator's text mininghttps://conductscience.org/library/genes/6261NCBI Gene
SLC29A23177PubTator's text mininghttps://conductscience.org/library/genes/3177NCBI Gene
SPEG10290PubTator's text mininghttps://conductscience.org/library/genes/10290NCBI Gene
TTN7273PubTator's text mininghttps://conductscience.org/library/genes/7273NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30103348

GET https://conductscience.org/api/papers/v1/30103348/references?page=2